Terril Brothers’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Terril Brothers’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,300	Closed	-$51K	–	60
2020 Q1	$51K	Buy	+19,300	New	+$31.6K	0.02%	52

Terril Brothers's NTGN Position: Q2 2020 in Review

Terril Brothers sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 19,300 shares — an estimated $51K sold.

Terril Brothers first reported a position in NTGN in Q1 2020 and held it in 1 quarter. The position peaked at $51K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Terril Brothers reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Terril Brothers sold 19,300 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $51K.
Terril Brothers first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Terril Brothers's Neon Therapeutics, Inc. Common Stock position peaked at $51K in Q1 2020.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Terril Brothers's 13F filing for Q2 2020, filed 4 Aug 2020.